Performance-Linked Director Compensation and Operating Profit KPI
First written in FY2022. 2 of 3 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 4 of 31 companies on the "Worse" side.
17 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「Performance-linked compensation and other compensation is paid in cash, incorporating performance indicators (KPIs) to raise awareness of improving performance in each fiscal year. The amount is calculated according to the degree of achievement of the consolidated operating profit target for each fiscal year and paid monthly.」
The policy of reflecting the degree of achievement of the consolidated operating profit target in performance-linked compensation as a KPI continues. - FY2023RestatedAnnual report
「Performance-linked compensation and other compensation is paid in cash, incorporating performance indicators (KPIs) to raise awareness of improving performance in each fiscal year. The amount is calculated according to the degree of achievement of the consolidated operating profit target for each fiscal year and paid monthly.」
The policy of reflecting the degree of achievement of the consolidated operating profit target in performance-linked compensation as a KPI continues. During the current fiscal year, a total of ¥8,310 thousand was paid to directors and others as performance-linked compensation. - FY2022First statedAnnual report
「Performance-linked compensation and other compensation is paid in cash, incorporating performance indicators (KPIs) to raise awareness of improving performance in each fiscal year. The amount is calculated according to the degree of achievement of the consolidated operating profit target for each fiscal year and paid monthly.」
For director compensation, this is the first disclosure of a policy to reflect the degree of achievement of the consolidated operating profit target in performance-linked compensation as a KPI. The target is set when the plan is formulated so that it is consistent with the medium-term management plan, and is to be reviewed in response to changes in the operating environment.